SocialPicks Monitor new  |    Stock Idea Community
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Investment Ideas Served Daily By People You Trust
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

4 pts

Opinion on  Nastech Pharmaceutical Company Inc. (NSTK)     Sector: Healthcare  >  Industry: Biotechnology & Drugs
Great price on pills, for once!

Jun 02, 2008 04:05 PM UTC
Trip_to_berlin_146
Return Risk
-29.72% LOW
Sr. Analyst

I've had my eye on this for a long time and I never thought it would get this low. This is a risky play like all pharm stocks but I feel that given the history of the company it's due for a least a little shot in the arm to at least 2.30 or so. Plus some news is suppose to be released soon about one of its cancer research projects. I hope its good news.

A target of around 1.90 would have been more realistic but, what the hell, this is the stock market and we've all been at the 'casino' lately!


NSTK:  This call was made on 06/02/08 @ $1.16
Rating:   Positive   $1.16 (06/02/08)
Closed:   07/23/2008 @ $1.19 (+2.59% in 51 days)
Target:   $2.30 (+98.28%) in Six months


Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 17.79 +39.36% 76
2 15.74 +15.90% 10
3 14.31 +16.71% 41
4 14.15 +22.86% 16
5 13.66 +30.39% 183


POPULAR STOCKS
Symbol Company Name Sentiment

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Nastech Pharmaceutical Company Inc. (NSTK)
   SocialPicks Sentiment:   

   This Quarter's Sentiment:
All:
64.5%
Top:
100.0%




Latest Picks by Brady
Symbol SP Sentiment Rating Return Since
FRE Positive -93.52% 07/23/08
MRNA N/A Positive -66.38% 07/23/08
SYNM Positive -58.50% 07/23/08
BBW Positive -35.03% 07/23/08
AVAL N/A Positive -79.59% 06/11/08

View All >
   




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch